{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T20:29:59Z","timestamp":1723235399917},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11,28]]},"DOI":"10.1097\/qad.0b013e328359a89d","type":"journal-article","created":{"date-parts":[[2012,11,15]],"date-time":"2012-11-15T06:54:03Z","timestamp":1352962443000},"page":"2275-2284","source":"Crossref","is-referenced-by-count":23,"title":["Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism"],"prefix":"10.1097","volume":"26","author":[{"given":"Jos\u00e9 M.","family":"Marcelino","sequence":"first","affiliation":[]},{"given":"Pedro","family":"Borrego","sequence":"additional","affiliation":[]},{"given":"Charlotta","family":"Nilsson","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Fam\u00edlia","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Barroso","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Maltez","sequence":"additional","affiliation":[]},{"given":"Manuela","family":"Doroana","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"Antunes","sequence":"additional","affiliation":[]},{"given":"Alexandre","family":"Quintas","sequence":"additional","affiliation":[]},{"given":"Nuno","family":"Taveira","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-2-20210130","first-page":"457","article-title":"Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection.","volume":"1","author":"Berry","year":"1998","journal-title":"J Hum Virol"},{"key":"R2-2-20210130","doi-asserted-by":"crossref","first-page":"12425","DOI":"10.1128\/JVI.01557-06","article-title":"Increased frequency of circulating CCR5 CD4 T cells in human immunodeficiency virus type 2 infection.","volume":"80","author":"Soares","year":"2006","journal-title":"J Virol"},{"key":"R3-2-20210130","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1126\/science.7915856","article-title":"Reduced rate of disease development after HIV-2 infection as compared to HIV-1.","volume":"265","author":"Marlink","year":"1994","journal-title":"Science"},{"key":"R4-2-20210130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/QAD.0b013e3282f4ddfc","article-title":"Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France.","volume":"22","author":"Drylewicz","year":"2008","journal-title":"AIDS"},{"key":"R5-2-20210130","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1097\/00002030-200012010-00007","article-title":"Marked immunosuppressive effects of the HIV-2 envelope protein in spite of the lower HIV-2 pathogenicity.","volume":"14","author":"Cavaleiro","year":"2000","journal-title":"AIDS"},{"key":"R6-2-20210130","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1002\/eji.200737511","article-title":"Monocyte-mediated T cell suppression by HIV-2 envelope proteins.","volume":"37","author":"Cavaleiro","year":"2007","journal-title":"Eur J Immunol"},{"key":"R7-2-20210130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nm0402-319","article-title":"CD4 T-cell depletion in HIV infection: are we closer to understanding the cause.","volume":"8","author":"Grossman","year":"2002","journal-title":"Nat Med"},{"key":"R8-2-20210130","doi-asserted-by":"crossref","first-page":"e1000667","DOI":"10.1371\/journal.ppat.1000667","article-title":"Major depletion of plasmacytoid dendritic cells in HIV-2 infection: an attenuated form of HIV disease.","volume":"5","author":"Cavaleiro","year":"2009","journal-title":"PLoS Pathog"},{"key":"R9-2-20210130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1586\/14760584.7.3.319","article-title":"Tenets of protection from progression to AIDS: lessons from the immune responses to HIV-2 infection.","volume":"7","author":"Leligdowicz","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"R10-2-20210130","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.4049\/jimmunol.176.11.6973","article-title":"Maintenance of HIV-specific CD4 T cell help distinguishes HIV-2 from HIV-1 infection.","volume":"176","author":"Duvall","year":"2006","journal-title":"J Immunol"},{"key":"R11-2-20210130","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/JVI.06315-11","article-title":"Potent intratype neutralizing activity distinguishes human immunodeficiency virus type 2 (HIV-2) from HIV-1.","volume":"86","author":"Ozkaya Sahin","year":"2012","journal-title":"J Virol"},{"key":"R12-2-20210130","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1128\/JVI.06155-11","article-title":"Broad and potent neutralizing antibody responses elicited in natural HIV-2 infection.","volume":"86","author":"Kong","year":"2012","journal-title":"J Virol"},{"key":"R13-2-20210130","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1128\/JVI.06126-11","article-title":"Potent autologous and heterologous neutralizing antibody responses occur in HIV-2 infection across a broad range of infection outcomes.","volume":"86","author":"de Silva","year":"2012","journal-title":"J Virol"},{"key":"R14-2-20210130","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1128\/JVI.02789-06","article-title":"Comparison of heterologous neutralizing antibody responses of human immunodeficiency virus type 1 (HIV-1)- and HIV-2-infected Senegalese patients: distinct patterns of breadth and magnitude distinguish HIV-1 and HIV-2 infections.","volume":"81","author":"Rodriguez","year":"2007","journal-title":"J Virol"},{"key":"R15-2-20210130","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1006\/viro.1993.1160","article-title":"Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection.","volume":"193","author":"Bjorling","year":"1993","journal-title":"Virology"},{"key":"R16-2-20210130","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1099\/vir.0.81259-0","article-title":"Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation.","volume":"86","author":"Shi","year":"2005","journal-title":"J Gen Virol"},{"key":"R17-2-20210130","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1128\/JVI.69.6.3333-3340.1995","article-title":"Neutralizing monoclonal antibodies against human immunodeficiency virus type 2 gp120.","volume":"69","author":"Matsushita","year":"1995","journal-title":"J Virol"},{"key":"R18-2-20210130","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.4049\/jimmunol.152.4.1952","article-title":"Two neutralizing domains in the V3 region in the envelope glycoprotein gp125 of HIV type 2.","volume":"152","author":"Bjorling","year":"1994","journal-title":"J Immunol"},{"key":"R19-2-20210130","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1073\/pnas.88.14.6082","article-title":"Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity.","volume":"88","author":"Bjorling","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R20-2-20210130","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1128\/JVI.64.7.3492-3499.1990","article-title":"Envelope cross-reactivity between human immunodeficiency virus types 1 and 2 detected by different serological methods: correlation between cross-neutralization and reactivity against the main neutralizing site.","volume":"64","author":"Bottiger","year":"1990","journal-title":"J Virol"},{"key":"R21-2-20210130","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1128\/JVI.66.6.3602-3608.1992","article-title":"Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates.","volume":"66","author":"Robert-Guroff","year":"1992","journal-title":"J Virol"},{"key":"R22-2-20210130","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1128\/JVI.70.7.4598-4606.1996","article-title":"Location, exposure, and conservation of neutralizing and nonneutralizing epitopes on human immunodeficiency virus type 2 SU glycoprotein.","volume":"70","author":"McKnight","year":"1996","journal-title":"J Virol"},{"key":"R23-2-20210130","doi-asserted-by":"crossref","first-page":"12429","DOI":"10.1128\/JVI.01102-10","article-title":"Potent and broadly reactive HIV-2 neutralizing antibodies elicited by a vaccinia virus vector prime-C2V3C3 polypeptide boost immunization strategy.","volume":"84","author":"Marcelino","year":"2010","journal-title":"J Virol"},{"key":"R24-2-20210130","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1128\/JCM.37.2.453-456.1999","article-title":"Quantitation of human immunodeficiency virus type 2 DNA in peripheral blood mononuclear cells by using a quantitative-competitive PCR assay.","volume":"37","author":"Gomes","year":"1999","journal-title":"J Clin Microbiol"},{"key":"R25-2-20210130","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1128\/JVI.72.4.3418-3422.1998","article-title":"Virological and molecular demonstration of human immunodeficiency virus type 2 vertical transmission.","volume":"72","author":"Cavaco-Silva","year":"1998","journal-title":"J Virol"},{"key":"R26-2-20210130","first-page":"374","article-title":"A capture enzyme immunoassay for detection of HIV-2SIV antigen.","volume":"4","author":"Thorstensson","year":"1991","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R27-2-20210130","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3851\/IMP1996","article-title":"Baseline susceptibility of primary HIV-2 to entry inhibitors.","volume":"17","author":"Borrego","year":"2012","journal-title":"Antivir Ther"},{"key":"R28-2-20210130","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-1-59745-170-3_26","article-title":"Measuring HIV neutralization in a luciferase reporter gene assay.","volume":"485","author":"Montefiori","year":"2009","journal-title":"Methods Mol Biol"},{"key":"R29-2-20210130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1.","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"},{"key":"R30-2-20210130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/bioinformatics\/bti770","article-title":"The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.","volume":"22","author":"Arnold","year":"2006","journal-title":"Bioinformatics"},{"key":"R31-2-20210130","doi-asserted-by":"crossref","first-page":"D387","DOI":"10.1093\/nar\/gkn750","article-title":"The SWISS-MODEL repository and associated resources.","volume":"37","author":"Kiefer","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"R32-2-20210130","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0968-0004(00)88963-X","article-title":"The Swiss-3DImage collection and PDB-Browser on the World-Wide Web.","volume":"20","author":"Peitsch","year":"1995","journal-title":"Trends Biochem Sci"},{"key":"R33-2-20210130","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03327","article-title":"Structure of an unliganded simian immunodeficiency virus gp120 core.","volume":"433","author":"Chen","year":"2005","journal-title":"Nature"},{"key":"R34-2-20210130","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/bip.360221211","article-title":"Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features.","volume":"22","author":"Kabsch","year":"1983","journal-title":"Biopolymers"},{"key":"R35-2-20210130","doi-asserted-by":"crossref","first-page":"D411","DOI":"10.1093\/nar\/gkq1105","article-title":"A series of PDB related databases for everyday needs.","volume":"39","author":"Joosten","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"R36-2-20210130","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1097\/QAD.0b013e3283155546","article-title":"Envelope-specific antibody response in HIV-2 infection: C2V3C3-specific IgG response is associated with disease progression.","volume":"22","author":"Marcelino","year":"2008","journal-title":"AIDS"},{"key":"R37-2-20210130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1742-4690-5-78","article-title":"The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients.","volume":"5","author":"Borrego","year":"2008","journal-title":"Retrovirology"},{"key":"R38-2-20210130","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1128\/JVI.79.3.1686-1700.2005","article-title":"CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia.","volume":"79","author":"Blaak","year":"2005","journal-title":"J Virol"},{"key":"R39-2-20210130","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1128\/JVI.01482-09","article-title":"Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables.","volume":"84","author":"Doria-Rose","year":"2010","journal-title":"J Virol"},{"key":"R40-2-20210130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nri2674","article-title":"The immune response during acute HIV-1 infection: clues for vaccine development.","volume":"10","author":"McMichael","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"R41-2-20210130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-030409-101256","article-title":"The role of antibodies in HIV vaccines.","volume":"28","author":"Mascola","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"R42-2-20210130","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/QAD.0b013e32833243e7","article-title":"Prevalence of cross-reactive HIV-1-neutralizing activity in HIV-1-infected patients with rapid or slow disease progression.","volume":"23","author":"van Gils","year":"2009","journal-title":"AIDS"},{"key":"R43-2-20210130","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1099\/vir.0.015693-0","article-title":"High prevalence of neutralizing activity against multiple unrelated human immunodeficiency virus type 1 (HIV-1) subtype B variants in sera from HIV-1 subtype B-infected individuals: evidence for subtype-specific rather than strain-specific neutralizing activity.","volume":"91","author":"van Gils","year":"2010","journal-title":"J Gen Virol"},{"key":"R44-2-20210130","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1097\/QAD.0b013e32834b3554","article-title":"Memory and naive-like regulatory CD4 T cells expand during HIV-2 infection in direct association with CD4 T-cell depletion irrespectively of viremia.","volume":"25","author":"Foxall","year":"2011","journal-title":"AIDS"},{"key":"R45-2-20210130","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.4049\/jimmunol.175.7.4180","article-title":"Cutting edge: direct suppression of B cells by CD4 CD25 regulatory T cells.","volume":"175","author":"Lim","year":"2005","journal-title":"J Immunol"},{"key":"R46-2-20210130","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.4049\/jimmunol.1101328","article-title":"Regulation of the germinal center reaction by foxp3 follicular regulatory T cells.","volume":"187","author":"Wollenberg","year":"2011","journal-title":"J Immunol"},{"key":"R47-2-20210130","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm.2425","article-title":"Foxp3 follicular regulatory T cells control the germinal center response.","volume":"17","author":"Linterman","year":"2011","journal-title":"Nat Med"},{"key":"R48-2-20210130","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1073\/pnas.0630530100","article-title":"Rapid evolution of the neutralizing antibody response to HIV type 1 infection.","volume":"100","author":"Richman","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R49-2-20210130","doi-asserted-by":"crossref","first-page":"7932","DOI":"10.1128\/JVI.00757-08","article-title":"Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection.","volume":"82","author":"Bunnik","year":"2008","journal-title":"J Virol"},{"key":"R50-2-20210130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.virol.2009.11.032","article-title":"Temporal analysis of HIV envelope sequence evolution and antibody escape in a subtype A-infected individual with a broad neutralizing antibody response.","volume":"398","author":"Bosch","year":"2010","journal-title":"Virology"},{"key":"R51-2-20210130","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1128\/JVI.72.3.1886-1893.1998","article-title":"Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage.","volume":"72","author":"Montefiori","year":"1998","journal-title":"J Virol"},{"key":"R52-2-20210130","doi-asserted-by":"crossref","first-page":"e3206","DOI":"10.1371\/journal.pone.0003206","article-title":"Net positive charge of HIV-1 CRF01AE V3 sequence regulates viral sensitivity to humoral immunity.","volume":"3","author":"Naganawa","year":"2008","journal-title":"PLoS One"},{"key":"R53-2-20210130","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.1128\/JVI.79.11.6957-6968.2005","article-title":"Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.","volume":"79","author":"Lusso","year":"2005","journal-title":"J Virol"},{"key":"R54-2-20210130","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0966-842X(00)88975-1","article-title":"Immune escape and tropism of HIV.","volume":"3","author":"McKnight","year":"1995","journal-title":"Trends Microbiol"},{"key":"R55-2-20210130","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1128\/JVI.69.5.3167-3170.1995","article-title":"Change in tropism upon immune escape by human immunodeficiency virus.","volume":"69","author":"McKnight","year":"1995","journal-title":"J Virol"},{"key":"R56-2-20210130","doi-asserted-by":"crossref","first-page":"8570","DOI":"10.1128\/JVI.77.15.8570-8576.2003","article-title":"Human immunodeficiency virus type 1 primary isolate neutralization resistance is associated with the syncytium-inducing phenotype and lower CD4 cell counts in subtype CRF01AE-infected patients.","volume":"77","author":"Polonis","year":"2003","journal-title":"J Virol"},{"key":"R57-2-20210130","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.virol.2006.05.029","article-title":"In vitro replication capacity of HIV-2 variants from long-term aviremic individuals.","volume":"353","author":"Blaak","year":"2006","journal-title":"Virology"},{"key":"R58-2-20210130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/infdis\/jir698","article-title":"Molecular determinants of HIV-2 R5-X4 tropism in the V3 loop: development of a new genotypic tool.","volume":"205","author":"Visseaux","year":"2011","journal-title":"J Infect Dis"},{"key":"R59-2-20210130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0969-2126(03)00011-X","article-title":"Alternative conformations of HIV-1 V3 loops mimic beta hairpins in chemokines, suggesting a mechanism for coreceptor selectivity.","volume":"11","author":"Sharon","year":"2003","journal-title":"Structure"},{"key":"R60-2-20210130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.str.2004.01.003","article-title":"Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D.","volume":"12","author":"Stanfield","year":"2004","journal-title":"Structure"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAD.0b013e328359a89d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T20:06:44Z","timestamp":1687810004000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201211280-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,28]]},"references-count":60,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328359a89d","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11,28]]}}}